THE MEXICO FUND, INC. ISSUES ITS 2024 ANNUAL REPORT

Published on December 26, 2024

The Mexico Fund , Inc. The Mexico Fund, Inc. is a non-diversified closed-end management investment company with the investment objective of

Continue reading on website
Other news

Marker Therapeutics director Steve Elms acquires $35,472 in stock

December 26, 2024
an indirect ownership of 325,370 shares, which are directly owned by Aisling Capital IV, LP, where Elms shares voting and dispositive power.

Viracta Therapeutics Announces Closure of NAVAL-1 Clinical Trial and Exploration of Strategic Alternatives

December 26, 2024
regarding its ability to fund ongoing operations into 2025, future expenses, capital requirements, and need for additional financing in the